← Open Payments lookup

JESSICA TOWNLEY: Open Payments

NPI 1265078547 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,217 in 69 payments from 16 companies in 2025. Trend: 2023 $1,687 · 2024 $1,226 · 2025 $1,217

Food & beverage: $1,217
CompanyPaymentsAmount
ABBVIE INC.19$271
Novo Nordisk Inc13$196
AstraZeneca Pharmaceuticals LP7$161
Sumitomo Pharma America, Inc.5$122
Lilly USA, LLC6$108
Otsuka America Pharmaceutical, Inc.4$80
Corcept Therapeutics3$50
Axsome Therapeutics, Inc.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Amgen Inc.2$28

Products named: QULIPTA, GEMTESA, MOUNJARO, REXULTI, Wegovy, VRAYLAR, AIRSUPRA, FARXIGA.

Industry payments across LA — which companies pay providers there.